Rani Therapeutics Holdings, Inc.

NasdaqGM:RANI Stock Report

Market Cap: US$80.4m

Rani Therapeutics Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:RANI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Dec 24BuyUS$29,993Kate McKinleyIndividual17,960US$1.67
09 Dec 24BuyUS$19,974Talat ImranIndividual10,296US$1.94
15 Oct 24SellUS$10,141,677South Lake Management LLCCompany3,829,360US$2.65
15 Oct 24SellUS$10,141,674South Lake Management LLCCompany3,829,360US$3.26

Insider Trading Volume

Insider Buying: RANI insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RANI?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,502,8454.51%
Hedge Funds2,574,0007.73%
Institutions3,192,6779.58%
Private Companies8,328,20125%
General Public17,713,82053.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.9%.

Top Shareholders

Top 25 shareholders own 46.08% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.9%
South Lake Management LLC
8,302,194US$20.0m-31.6%no data
7.73%
Armistice Capital LLC
2,574,000US$6.2m0%0.09%
2.13%
The Vanguard Group, Inc.
709,828US$1.7m0%no data
1.48%
Pivotal BioVenture Partners LLC
493,584US$1.2m0%0.27%
1.35%
GV Management Company, LLC
448,492US$1.1m0%0.04%
0.91%
USAA Investment Services Company
302,743US$730.7k-3%0.01%
0.84%
Laureen DeBuono
278,588US$672.4k0%no data
0.84%
Jean-Luc Butel
278,588US$672.4k0%no data
0.81%
Stifel Asset Management Corp.
269,768US$651.1k100%no data
0.66%
Dennis Ausiello
219,805US$530.5k0%no data
0.65%
Talat Imran
218,170US$526.6k29.2%no data
0.52%
Geode Capital Management, LLC
172,261US$415.8k14.3%no data
0.47%
Lisa Rometty
155,528US$375.4k0%no data
0.45%
Mir Hashim
148,415US$358.2k0%no data
0.42%
Svai Sanford
141,488US$341.5k0%no data
0.32%
Northern Trust Global Investments
105,634US$255.0k199%no data
0.24%
Luther King Capital Management Corporation
81,129US$195.8k44.5%no data
0.22%
Merrill Lynch & Co. Inc., Banking Investments
74,430US$179.6k-17.4%no data
0.21%
Bridgeway Capital Management, LLC
71,500US$172.6k0%no data
0.19%
BlackRock, Inc.
63,583US$153.5k0%no data
0.19%
Avenue Capital Group, LLC
62,887US$151.8k0%0.09%
0.16%
InCube Ventures, LLC
52,781US$127.4k0%17.49%
0.14%
MOTCO
48,129US$116.2k0%0.01%
0.13%
State Street Global Advisors, Inc.
42,042US$101.5k0%no data
0.1%
Renaissance Technologies LLC
33,199US$80.1k53%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 08:19
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rani Therapeutics Holdings, Inc. is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Geoffrey MeachamBofA Global Research
Julian HarrisonBTIG
Edward NashCanaccord Genuity